IonQ, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IonQ, Inc. on November 7, 2025, covering events occurring on November 7, 2025, and November 10, 2025. The filing relates to the execution of a Registration Rights Agreement and the subsequent filing of a prospectus supplement to facilitate the resale of common stock by a selling stockholder.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and securities registration rather than financial performance.
Material Changes
- Registration Rights Agreement: On November 7, 2025, IonQ, Inc. entered into a Registration Rights Agreement with The University of Chicago, effective November 10, 2025.
- Prospectus Supplement: On November 10, 2025, the Company filed a prospectus supplement to its Form S-3ASR Registration Statement (File No. 333-285279).
- Share Resale: The supplement covers the resale by The University of Chicago of an aggregate of 2,108,993 shares of IonQ common stock, par value $0.0001 per share.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific operational risks. The primary disclosure is the legal mechanism enabling the sale of shares by an institutional holder. The text notes that the description of the Registration Rights Agreement is qualified by reference to the full text filed as Exhibit 4.1.
Investor Verification Checklist
- Verify the full terms of the Registration Rights Agreement filed as Exhibit 4.1.
- Confirm the total number of shares (2,108,993) being resold by The University of Chicago.
- Review the underlying Form S-3ASR Registration Statement (File No. 333-285279) for broader context on the Company's capital structure.
- Check the legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP filed as Exhibit 5.1.